The female athlete triad and endothelial dysfunction

PM and R

Volumn 3, Issue 5, 2011, Pages 458-465

  Lanser, Erica M ^a   Zach, Karie N ^b   Hoch, Anne Z ^b  

^a MARQUETTE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLIC ACID; ORAL CONTRACEPTIVE AGENT;

AMENORRHEA; ARTICLE; ATHLETE; ENDOTHELIAL DYSFUNCTION; HUMAN; INJURY; PRIORITY JOURNAL; SPORT; VASCULAR DISEASE;

BONE DENSITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; DANCING; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FEMALE; FEMALE ATHLETE TRIAD SYNDROME; FOLIC ACID; HORMONE REPLACEMENT THERAPY; HUMANS; REGIONAL BLOOD FLOW; VASODILATION;

EID: 79955813661     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.12.024     Document Type: Article

References (69)

1. Lynch S.L., Hoch A.Z. The female runner: Gender specifics. Clin Sports Med 2010, 29:477-498.
2. DeHaas D.M. NCAA sports sponsorship and participation rates report 1981-1982 - 2007-2008 Accessed February 2, 2011. http://www.ncaapublications.com/p-3778-1981-82-2007-08-ncaa-sports-sponsorship-and-participation-rates.aspx.
3. Overall medal count by country The Vancouver Organizing Committee for the 2010 Olympic Games, Accessed February 2, 2011. http://www.olympic.org/medallists-results?athletename=%26category=343486%26games=3162585%26sport=%26event=%26mengender=false%26womengender=false%26mixedgender=false%26teamclassification=false%26individualclassification=false%26continent=1310308%26country=347777%26goldmedal=false%26silvermedal=false%26bronzemedal=false%26worldrecord=false%26olympicrecord=false%26targetresults=true.
4. Peterson N. Equal prize money for men, women at Aspen Winter X Games. The Aspen Times 2010 Published October 29, 2008. http://www.aspentimes.com/article/20081029/NEWS/810289923%26parentprofile=search.
5. Lopiano D. Gender equity in sports. Medical and Orthopedic Issues of Active and Athletic Women 1994, 13-22. Hanley & Belfus, Philadelphia, PA. R. Agostini (Ed.).
6. Ozanian M.K., Badenhausen K. The world's most valuable teams and athletes Accessed February 2, 2011. http://www.forbes.com/2010/07/20/most-valuable-athletes-and-teams-business-sports-sportsmoney-fifty-fifty.html.
7. Pomerantz D., Rose L. The Celebrity 100 Accessed February 2, 2011. http://www.forbes.com/lists/2010/53/celeb-100-10_The-Celebrity-100.html.
8. Earl J.E., Hoch A.Z. A proximal strengthening program improves pain, function, and biomechanics in women with patellofemoral pain syndrome. Am J Sports Med 2011, 39:154-163.
9. Ireland M.L., Willson J.D., Ballantyne B.T., Davis I.M. Hip strength in females with and without patellofemoral pain. J Orthop Sports Phys Ther 2003, 33:671-676.
10. Ferber R., Hreljac A., Kendall S. Suspected mechanism in the cause of overuse running injuries: A clinical review. Sports Health 2009, 1:242-246.
11. Horton M., Hall T. Quadriceps femoris muscle angle: Normal values and relationships with gender and selected skeletal measures. Phys Ther 1989, 69:897-901.
12. Dolan B., Lacey J.H., Evans C. Eating behaviour and attitudes to weight and shape in British women from three ethnic groups. Br J Psychiatry 1990, 157:523-528.
13. McCarthy M. The thin ideal, depression and eating disorders in women. Behav Res Ther 1990, 28:205-215.
14. Mussell M.P., Mitchell J.E., Crosby R.D., Fulkerson J.A., Hoberman H.M., Romano J.L. Commitment to treatment goals in prediction of group cognitive-behavioral therapy treatment outcome for women with bulimia nervosa. J Consulting Clin Psychol 2000, 68:432-437.
15. Stice E., Schupak-Neuberg E., Shaw H., Stein R. Relation of media exposure to eating disorder symptomatology. J Abnormal Psychol 1994, 103:836-840.
16. Sundgot-Borgen J. Risk and trigger factors for the development of eating disorders in female elite athletes. Med Sci Sports Exerc 1994, 26:414-419.
17. Otis C.L., Drinkwater B., Johnson M., Loucks A., Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997, 29:1669-1671.
18. Nattiv A., Loucks A.B., Manore M.M., Sanborn C.F., Sundgot-Borgen J., Warren M.P. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007, 39:1867-1882.
19. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004, 7:17-26. Writing Group for the ISCD Position Development Conference.
20. Leib E.S. Treatment of low bone mass in premenopausal women: When may it be appropriate?. Curr Osteoporos Rep 2005, 3:13-18.
21. Leslie W.D., Adler R.A., El Hajj F.G., et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: The 2005 ISCD official positions. J Clin Densitom 2006, 9:22-30.
22. Fehling P.C., Alekel L., Clasey J., Rector A., Stillman R.J. A comparison of bone mineral densities among female athletes in impact loading and active loading sports. Bone 1995, 17:205-210.
23. To W.W., Wong M.W., Lam I.Y. Bone mineral density differences between adolescent dancers and non-exercising adolescent females. J Pediatr Adolesc Gynecol 2005, 18:337-342.
24. Nickols-Richardson S.M., Modlesky C.M., O'Connor P.J., Lewis R.D. Premenarcheal gymnasts possess higher bone mineral density than controls. Med Sci Sports Exerc 2000, 32:63-69.
25. Torstveit M.K., Sundgot-Borgen J. Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: A comprehensive controlled study. Br J Sports Med 2005, 39:282-287.
26. Beals K.A., Hill A.K. The prevalence of disordered eating, menstrual dysfunction, and low bone mineral density among US collegiate athletes. Int J Sport Nutr Exerc Metab 2006, 16:1-23.
27. Nichols J.F., Rauh M.J., Lawson M.J., Ji M., Barkai H.S. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006, 160:137-142.
28. Hoch A.Z., Pajewski N.M., Moraski L., et al. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med 2009, 19:421-428.
29. Torstveit M.K., Sundgot-Borgen J. The female athlete triad: Are elite athletes at increased risk?. Med Sci Sports Exerc 2005, 37:184-193.
30. Torstveit M.K., Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc 2005, 37:1449-1459.
31. Torstveit M.K., Sundgot-Borgen J. Participation in leanness sports but not training volume is associated with menstrual dysfunction: A national survey of 1276 elite athletes and controls. Br J Sports Med 2005, 39:141-147.
32. Loucks A.B. Energy availability, not body fatness, regulates reproductive function in women. Exerc Sport Sci Rev 2003, 31:144-148.
33. Grilo C.M., Masheb R.M., Salant S.L. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial. Biol Psychiatry 2005, 57:1193-1201.
34. Casper J., Nattiv A., Kurtzman F. Resumption of menses with non-pharmacologic management in amenorrheic collegiate athletes. Clin J Sport Med 2006, 16:439-440.
35. Golden N.H., Jacobson M.S., Schebendach J., Solanto M.V., Hertz S.M., Shenker I.R. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997, 151:16-21.
36. Williams N.I., Helmreich D.L., Parfitt D.B., Caston-Balderrama A., Cameron J.L. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001, 86:5184-5193.
37. McNicholl D.M., Heaney L.G. The safety of bisphosphonate use in pre-menopausal women on corticosteroids. Curr Drug Safety 2010, 5:182-187.
38. Hoch A.Z., Dempsey R.L., Carrera G.F., et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction?. Med Sci Sports Exerc 2003, 35:377-383.
39. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., Hirschberg A.L. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005, 90:1354-1359.
40. Hoch A.Z., Lynch S.L., Jurva J.W., Schimke J.E., Gutterman D.D. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med 2010, 20:205-210.
41. Hoch A.Z., Papanek P., Azabo A., Widlansky M.E., Schimke J.E., Gutterman D.D. Association between the female triad athlete and endothelial dysfunction in dancers. Clin J Sport Med 2011, 21:119-125.
42. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993, 362:801-809.
43. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA 1991, 265:1861-1867.
44. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89:12E-17E.
45. Chambliss K.L., Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002, 23:665-686.
46. Balligand J.L., Feron O., Dessy C. eNOS Activation by physical forces: From short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 2009, 89:481-534.
47. Celermajer D.S. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 1998, 32(Suppl 3):S29-S32.
48. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-1115.
49. Thijssen D.H.J., Black M.A., Pyke K.E., et al. Assessment of flow mediated dilation (FMD) in humans: A methodological and technical guideline. Am J Physiol Heart Circ Physiol 2011, 300:H2-H12.
50. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
51. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997, 129:111-118.
52. Lieberman E.H., Gerhard M.D., Uehata A., et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996, 78:1210-1214.
53. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
54. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes D.R., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954.
55. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
56. Dusting G.J., Fennessy P., Yin Z.L., Gurevich V. Nitric oxide in atherosclerosis: Vascular protector or villain?. Clin Exp Pharmacol Physiol Suppl 1998, 25:S34-S41.
57. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., Hirschberg A.L. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005, 90:3162-3167.
58. Hoch A.Z., Papanek P., Havlik H.S., et al. Prevalence of the female athlete triad/tetrad in professional ballet dancers. Med Sci Sports Exerc 2009, 41:524.
59. Hoch A.Z., Pajewski N.M., Hoffmann R.G., Schimke J.E., Gutterman D.D. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med 2009, 8:123-129.
60. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
61. Chlebowski R.T., Anderson G.L., Gass M., et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010, 304:1684-1692.
62. Maxwell A.J., Anderson B.E., Cooke J.P. Nutritional therapy for peripheral arterial disease: A double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 2000, 5:11-19.
63. Verhaar M.C., Wever R.M., Kastelein J.J., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: A randomized placebo-controlled trial. Circulation 1999, 100:335-338.
64. Wilmink H.W., Stroes E.S., Erkelens W.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000, 20:185-188.
65. Moens A.L., Claeys M.J., Wuyts F.L., et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2007, 99:476-481.
66. Title L.M., Ur E., Giddens K., McQueen M.J., Nassar B.A. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteine-lowering. Vasc Med 2006, 11:101-109.
67. Title L.M., Cummings P.M., Giddens K., Genest J.J., Nassar B.A. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000, 36:758-765.
68. Woo K.S., Chook P., Chan L.L., et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002, 112:535-539.
69. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 2007, 297:2351-2359.